Drug-Induced Liver Injury Caused by Abiraterone Acetate in Patients With Prostate Cancer
Severe DILI is a potential complication of the administration of abiraterone acetate. We recommend close monitoring for liver injury during abiraterone acetate therapy, especially in the first few months.
Authors
- Toshiki Mugita
- Masahiro Kurokawa
- Sho Okada (ORCID: https://orcid.org/0000-0002-1957-2282)
- Yoshihiro Nakagami (ORCID: https://orcid.org/0000-0002-3181-2066)
- Kazuhiko Oshinomi (ORCID: https://orcid.org/0000-0003-3129-9079)
- Tatsuki Inoue (ORCID: https://orcid.org/0000-0002-2009-8805)
- Takashi Fukagai (ORCID: https://orcid.org/0000-0003-0261-6303)
- Masakazu Nagata
Institutions
- SHOWA Medical University (JP)
- SHOWA Medical University Hospital (JP)
Publication Details
- Journal
- Cureus
- Published
- 2025-05-05
- DOI
- https://doi.org/10.7759/cureus.83494
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 0.00